Monday's HotCopper Trends: Invictus exploration, Neuren's FDA tick | April 14, 2025

14 Apr 2025 12:08 (AEST)

The ASX has been up 1% higher at 7,721 points.

Invictus Energy (ASX:IVZ) has been among the most watched on HotCopper forums after the company confirmed Musuma-1 as the first high-impact exploration well to be drilled outside the Mukuyu gas-condensate discovery area, targeting a new play type in the Cabora Bassa Basin.

Invictus Energy has been 5.5 cents.

Neuren Pharmaceuticals (ASX:NEU) has also been trending on news the primary endpoints for its Phase 3 pivotal clinical trial of its drug in Phelan-McDermid syndrome have been confirmed in a meeting with the U.S. FDA.

Neuren has been $10.74.

And, finally, Bellevue Gold (ASX:BGL) has revised its full-year production guidance down and scrapped its five-year growth plan after “uncharacteristic geological factors” hindered the gold miner’s output in the March quarter.

The company will also soon be running a $156.5 million placement to provide working capital for a revised mine plan and de-risk its balance sheet.

Bellevue Gold was $1.145 before its trading suspension.

More market news

Kowtow: “Biggest day in financial history” on Trump’s tariffs retreat

Meet GeoGeorge: The HotCopper poster so accurate he got hired as an analyst

Join the discussion: See what’s trending right now on HotCopper, Australia’s largest stock forum, and be part of the conversations that move the markets.

The material provided in this article is for information only and should not be treated as investment advice. Viewers are encouraged to conduct their own research and consult with a certified financial advisor before making any investment decisions. For full disclaimer information, please clickhere.


arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.